nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ALB—chronic obstructive pulmonary disease	0.293	1	CbGaD
Mycophenolate mofetil—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0449	0.2	CbGbCtD
Mycophenolate mofetil—ALB—Prednisone—chronic obstructive pulmonary disease	0.0322	0.144	CbGbCtD
Mycophenolate mofetil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0317	0.141	CbGbCtD
Mycophenolate mofetil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0214	0.0955	CbGbCtD
Mycophenolate mofetil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0204	0.0911	CbGbCtD
Mycophenolate mofetil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0182	0.0812	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0178	0.0795	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0169	0.0751	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0107	0.0476	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0101	0.045	CbGbCtD
Mycophenolate mofetil—IMPDH2—respiratory system—chronic obstructive pulmonary disease	0.00202	0.0724	CbGeAlD
Mycophenolate mofetil—CES2—respiratory system—chronic obstructive pulmonary disease	0.00184	0.0658	CbGeAlD
Mycophenolate mofetil—IMPDH2—bronchus—chronic obstructive pulmonary disease	0.00166	0.0596	CbGeAlD
Mycophenolate mofetil—IMPDH1—bronchus—chronic obstructive pulmonary disease	0.00165	0.0592	CbGeAlD
Mycophenolate mofetil—IMPDH2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00163	0.0583	CbGeAlD
Mycophenolate mofetil—IMPDH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00162	0.0579	CbGeAlD
Mycophenolate mofetil—CES1—respiratory system—chronic obstructive pulmonary disease	0.00151	0.0542	CbGeAlD
Mycophenolate mofetil—CES2—bronchus—chronic obstructive pulmonary disease	0.00151	0.0542	CbGeAlD
Mycophenolate mofetil—IMPDH2—trachea—chronic obstructive pulmonary disease	0.00149	0.0535	CbGeAlD
Mycophenolate mofetil—IMPDH1—trachea—chronic obstructive pulmonary disease	0.00148	0.0532	CbGeAlD
Mycophenolate mofetil—CES2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00148	0.053	CbGeAlD
Mycophenolate mofetil—CES2—trachea—chronic obstructive pulmonary disease	0.00136	0.0486	CbGeAlD
Mycophenolate mofetil—CES1—connective tissue—chronic obstructive pulmonary disease	0.00133	0.0477	CbGeAlD
Mycophenolate mofetil—SLCO1B3—lung—chronic obstructive pulmonary disease	0.00119	0.0428	CbGeAlD
Mycophenolate mofetil—IMPDH2—lung—chronic obstructive pulmonary disease	0.00107	0.0385	CbGeAlD
Mycophenolate mofetil—IMPDH1—lung—chronic obstructive pulmonary disease	0.00107	0.0382	CbGeAlD
Mycophenolate mofetil—CES2—lung—chronic obstructive pulmonary disease	0.000976	0.0349	CbGeAlD
Mycophenolate mofetil—CES1—lung—chronic obstructive pulmonary disease	0.000803	0.0288	CbGeAlD
Mycophenolate mofetil—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000667	0.0239	CbGeAlD
Mycophenolate mofetil—ABCG2—lung—chronic obstructive pulmonary disease	0.000382	0.0137	CbGeAlD
Mycophenolate mofetil—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000354	0.0127	CbGeAlD
Mycophenolate mofetil—CYP3A5—lung—chronic obstructive pulmonary disease	0.000354	0.0127	CbGeAlD
Mycophenolate mofetil—ABCB1—trachea—chronic obstructive pulmonary disease	0.000262	0.00938	CbGeAlD
Mycophenolate mofetil—ABCB1—lung—chronic obstructive pulmonary disease	0.000188	0.00674	CbGeAlD
Mycophenolate mofetil—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.000612	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000182	0.000611	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.000611	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000182	0.000609	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.000606	CcSEcCtD
Mycophenolate mofetil—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000605	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00018	0.000605	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00018	0.000604	CcSEcCtD
Mycophenolate mofetil—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.000603	CcSEcCtD
Mycophenolate mofetil—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000602	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000179	0.000599	CcSEcCtD
Mycophenolate mofetil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.000594	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.000594	CcSEcCtD
Mycophenolate mofetil—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00059	CcSEcCtD
Mycophenolate mofetil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000175	0.000588	CcSEcCtD
Mycophenolate mofetil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.000588	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.000588	CcSEcCtD
Mycophenolate mofetil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.000585	CcSEcCtD
Mycophenolate mofetil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000585	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000583	CcSEcCtD
Mycophenolate mofetil—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000582	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00058	CcSEcCtD
Mycophenolate mofetil—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000579	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000577	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000171	0.000575	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.000574	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000573	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000573	CcSEcCtD
Mycophenolate mofetil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.000569	CcSEcCtD
Mycophenolate mofetil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00017	0.000569	CcSEcCtD
Mycophenolate mofetil—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000566	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.000566	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000562	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.000561	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000167	0.000561	CcSEcCtD
Mycophenolate mofetil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.000559	CcSEcCtD
Mycophenolate mofetil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000167	0.000559	CcSEcCtD
Mycophenolate mofetil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000166	0.000558	CcSEcCtD
Mycophenolate mofetil—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000556	CcSEcCtD
Mycophenolate mofetil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.000555	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.000554	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000165	0.000554	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000165	0.000554	CcSEcCtD
Mycophenolate mofetil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.000552	CcSEcCtD
Mycophenolate mofetil—Injury—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000548	CcSEcCtD
Mycophenolate mofetil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000164	0.000548	CcSEcCtD
Mycophenolate mofetil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.000547	CcSEcCtD
Mycophenolate mofetil—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000545	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.000543	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000162	0.000543	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000162	0.000543	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000541	CcSEcCtD
Mycophenolate mofetil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.000538	CcSEcCtD
Mycophenolate mofetil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000161	0.000538	CcSEcCtD
Mycophenolate mofetil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000161	0.000538	CcSEcCtD
Mycophenolate mofetil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.000538	CcSEcCtD
Mycophenolate mofetil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000537	CcSEcCtD
Mycophenolate mofetil—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000536	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.000534	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000159	0.000532	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00053	CcSEcCtD
Mycophenolate mofetil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.000528	CcSEcCtD
Mycophenolate mofetil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000157	0.000527	CcSEcCtD
Mycophenolate mofetil—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.000527	CcSEcCtD
Mycophenolate mofetil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000157	0.000526	CcSEcCtD
Mycophenolate mofetil—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000524	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000524	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.000523	CcSEcCtD
Mycophenolate mofetil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.000521	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.000521	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000519	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000155	0.000519	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.000519	CcSEcCtD
Mycophenolate mofetil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.000518	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000517	CcSEcCtD
Mycophenolate mofetil—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000516	CcSEcCtD
Mycophenolate mofetil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000154	0.000516	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.000515	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000154	0.000515	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000513	CcSEcCtD
Mycophenolate mofetil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000508	CcSEcCtD
Mycophenolate mofetil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000508	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000504	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000504	CcSEcCtD
Mycophenolate mofetil—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000504	CcSEcCtD
Mycophenolate mofetil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000149	0.0005	CcSEcCtD
Mycophenolate mofetil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000149	0.0005	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000498	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000498	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000498	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000498	CcSEcCtD
Mycophenolate mofetil—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000496	CcSEcCtD
Mycophenolate mofetil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000148	0.000496	CcSEcCtD
Mycophenolate mofetil—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000492	CcSEcCtD
Mycophenolate mofetil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.000492	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.000491	CcSEcCtD
Mycophenolate mofetil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.000491	CcSEcCtD
Mycophenolate mofetil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00049	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00049	CcSEcCtD
Mycophenolate mofetil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000146	0.000489	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000488	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000145	0.000487	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000145	0.000487	CcSEcCtD
Mycophenolate mofetil—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000486	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000486	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000482	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00048	CcSEcCtD
Mycophenolate mofetil—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000479	CcSEcCtD
Mycophenolate mofetil—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000477	CcSEcCtD
Mycophenolate mofetil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000472	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00047	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.00047	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.000464	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000138	0.000464	CcSEcCtD
Mycophenolate mofetil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000138	0.000463	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.000462	CcSEcCtD
Mycophenolate mofetil—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000459	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000136	0.000454	CcSEcCtD
Mycophenolate mofetil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000452	CcSEcCtD
Mycophenolate mofetil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000452	CcSEcCtD
Mycophenolate mofetil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.000445	CcSEcCtD
Mycophenolate mofetil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000133	0.000445	CcSEcCtD
Mycophenolate mofetil—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000444	CcSEcCtD
Mycophenolate mofetil—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000444	CcSEcCtD
Mycophenolate mofetil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000132	0.000442	CcSEcCtD
Mycophenolate mofetil—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000438	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.000438	CcSEcCtD
Mycophenolate mofetil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00013	0.000436	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000431	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000431	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000429	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000427	CcSEcCtD
Mycophenolate mofetil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000426	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000422	CcSEcCtD
Mycophenolate mofetil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00042	CcSEcCtD
Mycophenolate mofetil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.000416	CcSEcCtD
Mycophenolate mofetil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000124	0.000416	CcSEcCtD
Mycophenolate mofetil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000122	0.000408	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000407	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000407	CcSEcCtD
Mycophenolate mofetil—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000401	CcSEcCtD
Mycophenolate mofetil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000119	0.0004	CcSEcCtD
Mycophenolate mofetil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.0004	CcSEcCtD
Mycophenolate mofetil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000397	CcSEcCtD
Mycophenolate mofetil—Rash—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000397	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000396	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000396	CcSEcCtD
Mycophenolate mofetil—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000396	CcSEcCtD
Mycophenolate mofetil—Headache—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000394	CcSEcCtD
Mycophenolate mofetil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000394	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000394	CcSEcCtD
Mycophenolate mofetil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.000393	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000393	CcSEcCtD
Mycophenolate mofetil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000392	CcSEcCtD
Mycophenolate mofetil—Rash—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000389	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000388	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000387	CcSEcCtD
Mycophenolate mofetil—Depression—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000387	CcSEcCtD
Mycophenolate mofetil—Headache—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000386	CcSEcCtD
Mycophenolate mofetil—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000383	CcSEcCtD
Mycophenolate mofetil—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000382	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000381	CcSEcCtD
Mycophenolate mofetil—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000381	CcSEcCtD
Mycophenolate mofetil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000378	CcSEcCtD
Mycophenolate mofetil—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000377	CcSEcCtD
Mycophenolate mofetil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000375	CcSEcCtD
Mycophenolate mofetil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000375	CcSEcCtD
Mycophenolate mofetil—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000375	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000374	CcSEcCtD
Mycophenolate mofetil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.000374	CcSEcCtD
Mycophenolate mofetil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000112	0.000374	CcSEcCtD
Mycophenolate mofetil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000372	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000367	CcSEcCtD
Mycophenolate mofetil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000109	0.000366	CcSEcCtD
Mycophenolate mofetil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000362	CcSEcCtD
Mycophenolate mofetil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000361	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000355	CcSEcCtD
Mycophenolate mofetil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000353	CcSEcCtD
Mycophenolate mofetil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000351	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00035	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000349	CcSEcCtD
Mycophenolate mofetil—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000347	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000343	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000341	CcSEcCtD
Mycophenolate mofetil—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000341	CcSEcCtD
Mycophenolate mofetil—Shock—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000335	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	9.93e-05	0.000333	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.83e-05	0.000329	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000326	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.44e-05	0.000316	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.000311	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.2e-05	0.000308	CcSEcCtD
Mycophenolate mofetil—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.000308	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.13e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.11e-05	0.000305	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.06e-05	0.000303	CcSEcCtD
Mycophenolate mofetil—Pain—Prednisolone—chronic obstructive pulmonary disease	8.7e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.4e-05	0.000282	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.38e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.00028	CcSEcCtD
Mycophenolate mofetil—Agitation—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000279	CcSEcCtD
Mycophenolate mofetil—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.000277	CcSEcCtD
Mycophenolate mofetil—Malaise—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.000274	CcSEcCtD
Mycophenolate mofetil—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.14e-05	0.000273	CcSEcCtD
Mycophenolate mofetil—Syncope—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.08e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Convulsion—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.000263	CcSEcCtD
Mycophenolate mofetil—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.82e-05	0.000262	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.68e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.000255	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.49e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.39e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Oedema—Prednisone—chronic obstructive pulmonary disease	7.39e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Infection—Prednisone—chronic obstructive pulmonary disease	7.34e-05	0.000246	CcSEcCtD
Mycophenolate mofetil—Shock—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.21e-05	0.000242	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.14e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.73e-05	0.000225	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.68e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.64e-05	0.000222	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.51e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisolone—chronic obstructive pulmonary disease	6.37e-05	0.000214	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.33e-05	0.000404	CbGpPWpGaD
Mycophenolate mofetil—Constipation—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000212	CcSEcCtD
Mycophenolate mofetil—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	6.32e-05	0.000404	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.28e-05	0.000401	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.27e-05	0.0004	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.24e-05	0.000399	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.21e-05	0.000397	CbGpPWpGaD
Mycophenolate mofetil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.04e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.03e-05	0.000385	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.01e-05	0.000384	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.9e-05	0.000377	CbGpPWpGaD
Mycophenolate mofetil—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.87e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000196	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000196	CcSEcCtD
Mycophenolate mofetil—UGT1A8—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.84e-05	0.000373	CbGpPWpGaD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	5.82e-05	0.000372	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.82e-05	0.000372	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.74e-05	0.000366	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.58e-05	0.000357	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.58e-05	0.000357	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.57e-05	0.000356	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.56e-05	0.000355	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.54e-05	0.000354	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.54e-05	0.000354	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.52e-05	0.000352	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.51e-05	0.000352	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.49e-05	0.00035	CbGpPWpGaD
Mycophenolate mofetil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.44e-05	0.000347	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GC—chronic obstructive pulmonary disease	5.43e-05	0.000347	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—ALB—chronic obstructive pulmonary disease	5.43e-05	0.000347	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GC—chronic obstructive pulmonary disease	5.43e-05	0.000347	CbGpPWpGaD
Mycophenolate mofetil—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000178	CcSEcCtD
Mycophenolate mofetil—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.23e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.19e-05	0.000332	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.19e-05	0.000331	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	5.16e-05	0.00033	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.13e-05	0.000328	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.13e-05	0.000328	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.12e-05	0.000327	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.12e-05	0.000327	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.07e-05	0.000324	CbGpPWpGaD
Mycophenolate mofetil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—UGT1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.05e-05	0.000322	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.05e-05	0.000322	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	5.01e-05	0.00032	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	4.98e-05	0.000318	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	4.95e-05	0.000316	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.9e-05	0.000313	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000164	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.85e-05	0.00031	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	4.84e-05	0.000309	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—ALB—chronic obstructive pulmonary disease	4.84e-05	0.000309	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	4.74e-05	0.000303	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	4.74e-05	0.000303	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.74e-05	0.000303	CbGpPWpGaD
Mycophenolate mofetil—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.000157	CcSEcCtD
Mycophenolate mofetil—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.7e-05	0.0003	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.69e-05	0.000299	CbGpPWpGaD
Mycophenolate mofetil—Rash—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000156	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000156	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.64e-05	0.000296	CbGpPWpGaD
Mycophenolate mofetil—Headache—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metabolism—NOS3—chronic obstructive pulmonary disease	4.63e-05	0.000296	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.63e-05	0.000295	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	4.61e-05	0.000294	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.57e-05	0.000292	CbGpPWpGaD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.51e-05	0.000288	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	4.44e-05	0.000283	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—ALB—chronic obstructive pulmonary disease	4.43e-05	0.000283	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.41e-05	0.000282	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.35e-05	0.000278	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.28e-05	0.000274	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.26e-05	0.000272	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.23e-05	0.00027	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.22e-05	0.00027	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	4.19e-05	0.000268	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.18e-05	0.000267	CbGpPWpGaD
Mycophenolate mofetil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.14e-05	0.000265	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.14e-05	0.000264	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.07e-05	0.00026	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.05e-05	0.000258	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.04e-05	0.000258	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.02e-05	0.000257	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.02e-05	0.000257	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	4e-05	0.000255	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.97e-05	0.000253	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.87e-05	0.000247	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.85e-05	0.000246	CbGpPWpGaD
Mycophenolate mofetil—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.82e-05	0.000244	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—ALB—chronic obstructive pulmonary disease	3.76e-05	0.00024	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.76e-05	0.00024	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.73e-05	0.000238	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.69e-05	0.000235	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.67e-05	0.000235	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.65e-05	0.000233	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.65e-05	0.000233	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	3.61e-05	0.00023	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.6e-05	0.00023	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.59e-05	0.00023	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.59e-05	0.000229	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.55e-05	0.000226	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.4e-05	0.000217	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.39e-05	0.000217	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.36e-05	0.000215	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.35e-05	0.000214	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.3e-05	0.000211	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	3.29e-05	0.00021	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.22e-05	0.000206	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.16e-05	0.000202	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.15e-05	0.000201	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.12e-05	0.000199	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.08e-05	0.000197	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.07e-05	0.000196	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.06e-05	0.000195	CbGpPWpGaD
Mycophenolate mofetil—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.04e-05	0.000194	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.03e-05	0.000194	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.97e-05	0.000189	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.97e-05	0.000189	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.96e-05	0.000189	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.94e-05	0.000188	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.93e-05	0.000187	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.93e-05	0.000187	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.92e-05	0.000187	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.92e-05	0.000186	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.91e-05	0.000186	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.9e-05	0.000185	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.9e-05	0.000185	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.86e-05	0.000183	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.84e-05	0.000182	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.8e-05	0.000179	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.77e-05	0.000177	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—ALB—chronic obstructive pulmonary disease	2.75e-05	0.000175	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.73e-05	0.000175	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.72e-05	0.000174	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.69e-05	0.000172	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.68e-05	0.000171	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.68e-05	0.000171	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.66e-05	0.00017	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.64e-05	0.000169	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.63e-05	0.000168	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.58e-05	0.000165	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.56e-05	0.000164	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.54e-05	0.000162	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.53e-05	0.000162	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.52e-05	0.000161	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.51e-05	0.00016	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.5e-05	0.000159	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.49e-05	0.000159	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.49e-05	0.000159	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.47e-05	0.000157	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.47e-05	0.000157	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.45e-05	0.000157	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.44e-05	0.000156	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.38e-05	0.000152	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.38e-05	0.000152	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.33e-05	0.000149	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.32e-05	0.000148	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.27e-05	0.000145	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.27e-05	0.000145	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.26e-05	0.000144	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.21e-05	0.000141	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000141	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.12e-05	0.000135	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.11e-05	0.000134	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.1e-05	0.000134	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.09e-05	0.000134	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.07e-05	0.000133	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.07e-05	0.000132	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.06e-05	0.000131	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.06e-05	0.000131	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.04e-05	0.00013	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.03e-05	0.00013	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.03e-05	0.00013	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.99e-05	0.000127	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.93e-05	0.000123	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.9e-05	0.000121	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.89e-05	0.000121	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.89e-05	0.000121	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.88e-05	0.00012	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.87e-05	0.000119	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.86e-05	0.000119	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.86e-05	0.000119	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.8e-05	0.000115	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000114	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000114	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.78e-05	0.000114	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.77e-05	0.000113	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.74e-05	0.000111	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.73e-05	0.000111	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.72e-05	0.00011	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	1.66e-05	0.000106	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.64e-05	0.000105	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.63e-05	0.000104	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.6e-05	0.000102	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.59e-05	0.000101	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.58e-05	0.000101	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.58e-05	0.000101	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.56e-05	9.99e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.56e-05	9.98e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.55e-05	9.92e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.54e-05	9.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.54e-05	9.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.53e-05	9.8e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	9.71e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.5e-05	9.61e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.5e-05	9.57e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	1.5e-05	9.57e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.44e-05	9.19e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.43e-05	9.15e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.43e-05	9.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.41e-05	9e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.4e-05	8.95e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	8.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	8.59e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.3e-05	8.29e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	8.24e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.25e-05	7.98e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.23e-05	7.87e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	7.84e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.22e-05	7.78e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ALB—chronic obstructive pulmonary disease	1.22e-05	7.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.19e-05	7.62e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	7.44e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	7.44e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.15e-05	7.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	7.22e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	1.12e-05	7.13e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.09e-05	6.96e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.08e-05	6.92e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	6.92e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	6.88e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.07e-05	6.82e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.07e-05	6.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.06e-05	6.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-05	6.6e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.95e-06	6.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.95e-06	6.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.89e-06	6.32e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.88e-06	6.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.43e-06	6.02e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.43e-06	6.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.38e-06	5.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.3e-06	5.94e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.67e-06	5.54e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.38e-06	5.35e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.29e-06	5.29e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.22e-06	5.25e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	8.19e-06	5.23e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.56e-06	4.83e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.4e-06	4.73e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.08e-06	4.52e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.97e-06	4.45e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	6.41e-06	4.09e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	6.13e-06	3.92e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.1e-06	3.89e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.81e-06	3.71e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.73e-06	3.66e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	5.59e-06	3.57e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.34e-06	3.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.34e-06	3.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.06e-06	3.23e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.44e-06	2.2e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.29e-06	2.1e-05	CbGpPWpGaD
